MANTERO, MARCO
 Distribuzione geografica
Continente #
EU - Europa 2.910
NA - Nord America 2.546
AS - Asia 1.326
SA - Sud America 85
AF - Africa 22
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.921
Nazione #
US - Stati Uniti d'America 2.459
GB - Regno Unito 1.339
IT - Italia 549
CN - Cina 486
SG - Singapore 387
SE - Svezia 246
DE - Germania 196
RU - Federazione Russa 165
IE - Irlanda 107
IN - India 101
CA - Canada 82
ID - Indonesia 82
BR - Brasile 63
HK - Hong Kong 62
DK - Danimarca 61
FR - Francia 52
TR - Turchia 52
KR - Corea 38
FI - Finlandia 32
UA - Ucraina 30
VN - Vietnam 24
JP - Giappone 20
ES - Italia 19
NL - Olanda 19
AU - Australia 17
CH - Svizzera 17
TW - Taiwan 14
BE - Belgio 13
EU - Europa 13
AT - Austria 12
TH - Thailandia 12
GR - Grecia 11
PH - Filippine 9
RO - Romania 7
AR - Argentina 6
DZ - Algeria 6
EG - Egitto 5
ET - Etiopia 5
MX - Messico 5
PL - Polonia 5
RS - Serbia 5
CO - Colombia 4
CZ - Repubblica Ceca 4
LB - Libano 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
PT - Portogallo 4
VE - Venezuela 4
AM - Armenia 3
BD - Bangladesh 3
EC - Ecuador 3
IR - Iran 3
LU - Lussemburgo 3
MY - Malesia 3
NO - Norvegia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AL - Albania 1
EE - Estonia 1
JO - Giordania 1
KG - Kirghizistan 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
TG - Togo 1
Totale 6.923
Città #
Southend 1.283
Fairfield 294
Singapore 266
Chandler 251
Milan 222
Ashburn 148
Houston 147
Wilmington 142
Woodbridge 136
Ann Arbor 130
Seattle 115
Cambridge 110
Dublin 102
Princeton 101
Council Bluffs 95
Beijing 73
Jakarta 70
Dearborn 64
Toronto 58
Santa Clara 56
Hong Kong 49
Des Moines 39
Nanjing 37
Hanover 34
Boardman 30
Bengaluru 28
Frankfurt am Main 27
Phoenix 26
Mountain View 25
Guangzhou 22
Shanghai 22
Rome 21
Grafing 20
Shenyang 20
Berlin 18
Hebei 17
Munich 17
Los Angeles 16
Nuremberg 16
Redmond 16
Redwood City 16
San Diego 15
Sunnyvale 15
Changsha 14
Silver Spring 13
Hangzhou 12
Jinan 12
Fuzhou 11
Helsinki 11
São Paulo 11
Jiaxing 10
London 10
Madrid 10
Naples 10
Taipei 10
Brussels 9
Chengdu 9
Genoa 9
Nanchang 9
Turin 9
Central District 8
Hefei 8
Kent 8
Quanzhou 8
Tianjin 8
Zurich 8
Lanzhou 7
Medford 7
Seoul 7
Vienna 7
Wuhan 7
Baltimore 6
Florence 6
Haikou 6
Miami 6
New York 6
Zhengzhou 6
Austin 5
Bangkok 5
Barcelona 5
Bühl 5
Chongqing 5
Eitensheim 5
Fremont 5
Genova 5
Hanoi 5
Jacksonville 5
Lappeenranta 5
Ningbo 5
Parma 5
Sakarya 5
Yokohama 5
Athens 4
Belgrade 4
Bitonto 4
Can Tho 4
Changchun 4
Chicago 4
Como 4
Dallas 4
Totale 4.814
Nome #
Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy 628
Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy 303
Non-Intensive Care Unit Acquired Pneumonia : A New Clinical Entity? 205
Acute exacerbations of COPD : risk factors for failure and relapse 205
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis : serum inflammatory biomarkers, clinical efficacy,and microbiological eradication 204
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 201
Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection 190
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis 186
Interstitial pneumonia with autoimmune features : An additional risk factor for ARDS? 179
Proteome Investigation of Rat Lungs subjected to Ex Vivo Perfusion (EVLP) 172
The evidence on tiotropium bromide in asthma: from the rationale to the bedside 165
Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendations 162
COVID-19 multidisciplinary high dependency unit: the Milan model 162
Management of severe COPD exacerbations : focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide 158
Quality standards for the management of bronchiectasis in Italy : a national audit 157
COPD management as a model for all chronic respiratory conditions : report of the 4th Consensus Conference in Respiratory Medicine 145
Application of machine learning to predict obstructive sleep apnea syndrome severity 143
Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease 141
Mucormycosis in CAPA, a possible fungal super-infection 138
Compliance with anti-H1N1 vaccine among healthcare workers and general population 131
Update on the management of pediatric acute osteomyelitis and septic arthritis 131
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 128
Impact of exacerbations in the natural course of COPD 126
Vaccinazione antipneumococcica negli adulti: raccomandazioni della Società italiana di medicina respiratoria (SIMeR) e della Società italiana di igiene, medicina preventiva e Sanità pubblica (SItI)=Pneumococcal vaccination in adults: recommendations from the Italian society of respiratory medicine (SIMeR) and the Italian society of hygiene, preventicve medicine and public health (SItI) 125
Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy 123
Effect of continuous positive airway pressure on respiratory drive in patients with obstructive sleep apnea 121
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 118
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia 117
Antibiotics as immunomodulant agents in COPD 115
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 112
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 108
Pneumonia due to Mycoplasma, Chlamydophila and Legionella 103
Emerging antibacterial and antiviral drugs for treating respiratory tract infections 96
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients 91
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 90
Knowledge and attitudes on influenza vaccination among Italian physicians specialized in respiratory infections : an Italian Respiratory Society (SIP/IRS) web-based survey 89
Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease 79
Protease–antiprotease imbalance in bronchiectasis 78
Time to active sitting position: One-year findings from a temporary COVID-19 intensive care unit 78
Understanding the burden of pneumococcal disease in adults 77
An ounce of prevention is worth a pound of cure 77
Physiotherapy approach after lung transplantation in a critically ill COVID-19 patient: a case report 74
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 69
Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study 66
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 65
Emerging biological therapies for treating chronic obstructive pulmonary disease : a pairwise and network meta-analysis 62
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 61
Treatable traits in interstitial lung diseases: a call to action 59
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 59
The role of vaccination in preventing pneumococcal disease in adults 57
Post-COVID-19 sequelae 56
Therapeutic approach to respiratory infections in lung transplantation 55
Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey 50
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department 47
Respiratory involvement in Fabry disease 46
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 43
Walking the path of treatable traits in interstitial lung diseases 39
Use of Dupilumab in Asthma Relapse After Lung Transplant 38
Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study 38
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 34
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 33
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 33
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study 22
Microbiological surveillance after lung transplantat: focus on fungi 19
null 3
null 3
null 3
null 3
Totale 7.294
Categoria #
all - tutte 23.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020232 0 0 0 0 0 0 0 0 0 123 54 55
2020/2021925 44 68 41 82 87 81 61 152 81 87 91 50
2021/2022771 66 50 50 39 46 50 71 51 104 72 34 138
2022/2023967 103 98 74 82 109 162 44 78 97 19 58 43
2023/2024742 22 52 36 41 158 65 55 23 28 53 79 130
2024/20251.050 80 179 48 154 171 76 72 188 81 1 0 0
Totale 7.294